CVE-2026-8662: Path Traversal vulnerability in the create_archive function of Rapid7 InsightConnect Compression Plugin on Lin
CVE-2026-8662 is a low-severity flaw (CVSS 3.3) affecting insightconnect compression. Below: why it ranks where it does, which versions are affected, what to do, and the exact commands.
Path Traversal vulnerability in the create_archive function of Rapid7 InsightConnect Compression Plugin on Linux allows authenticated attackers to write to unintended file paths via crafted filename input. The impact is limited to file corruption as content cannot be controlled by the attacker.
Why this priority
- No elevated risk signals yet
A fixed release or distro patch exists.
Risk facts
| CVSS score | 3.3 (Low) |
| Attack vector | Network (remote) |
| Attack complexity | High |
| Privileges needed | High |
| User interaction | None |
| EPSS exploit chance | 0.3% (top 78%) |
| CISA exploited list | No |
| Weakness | CWE-22 |
| Published | 2026-06-25 |
| Last modified | 2026-10-25 |
Last updated 2026-10-25 · Sources: CVE Program, NVD, CISA KEV, EPSS and vendor advisories · How we score
Am I affected?
Timeline
- Published CVE record published
- Updated Record last modified
Scores and fixes here are computed automatically from those and other public sources. Confirm with the vendor advisory before changing production systems.
Quick answers
How do I fix CVE-2026-8662?
insightconnect compression: upgrade to 2.0.3. Exact commands for each OS are on this page.
Is CVE-2026-8662 being exploited?
CVE-2026-8662 is not on the CISA Known Exploited Vulnerabilities list at the time of the last update. Check again, as this can change.
What does CVE-2026-8662 affect?
CVE-2026-8662 affects insightconnect compression. Severity is low (CVSS 3.3). Path Traversal vulnerability in the create_archive function of Rapid7 InsightConnect Compression Plugin on Linux allows authenticated attackers to write to unintended file paths via crafted filename input. The impact is limited to file corr
How urgent is CVE-2026-8662?
Priority 17/100. No elevated risk signals yet.